This trial will test if the "Hello Game" can help people with heart devices talk about end-of-life matters with their families.
6 Primary · 0 Secondary · Reporting Duration: At study completion, up to 3 months post intervention
Active Control
Experimental Treatment
120 Total Participants · 2 Treatment Groups
Primary Treatment: GAME-EOL · No Placebo Group · N/A
Age 18 - 99 · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:| Kentucky | 100.0% |
| 18 - 65 | 100.0% |
| University of Kentucky | 100.0% |
| Did not meet criteria | 100.0% |